6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
34m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
34m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
34m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
34m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Quince Therapeutics, Inc. (NASDAQ:QNCX) — investor relations, events, news, and company updates on 6ix.

Latest News

Quince Therapeutics Settles Approximately $16.4 Million of Debt

Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives

Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia

Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting

Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia

Financials

Revenue

$0

Market Cap

$4.87 M

EPS

-1.20

Community Chat

Ask AI